Reasner CA.
Effects of long-term fenofibrate therapy on cardiovascular events in people with type 2 diabetes mellitus.
Curr Atheroscler Rep. 2006 Jul;8(4):261-2. No abstract available.
PMID: 16822390

Reasner CA.
What is the most effective strategy for managing diabetic dyslipidaemia?
Atheroscler Suppl. 2005 Sep;6(3):21-7. Review.
PMID: 16054442

Rosenson RS, Reasner CA.
Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes.
Curr Opin Cardiol. 2004 Sep;19(5):480-7. Review.
PMID: 15316457

Blonde L, Dailey GE, Jabbour SA, Reasner CA, Mills DJ.
Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
Curr Med Res Opin. 2004 Apr;20(4):565-72.
PMID: 15119994

Reasner CA.
Where thiazolidinediones will fit.
Diabetes Metab Res Rev. 2002 Mar-Apr;18 Suppl 2:S30-5. Review.
PMID: 11921436

Hao ST, Reasner CA 2nd, Becker RA.
Use of cold iodine in patients with Graves' disease: observations from a clinical practice.
Endocr Pract. 2001 Nov-Dec;7(6):438-42.
PMID: 11747279

Reasner CA, Defronzo RA.
Treatment of type 2 diabetes mellitus: a rational approach based on its pathophysiology.
Am Fam Physician. 2001 May 1;63(9):1687-8, 1691-2, 1694. No abstract available.
PMID: 11352280

Reasner CA 2nd.
Promising new approaches.
Diabetes Obes Metab. 1999 May;1 Suppl 1:S41-8. Review.
PMID: 11220287

Khosla S, Hassoun AA, Baker BK, Liu F, Zein NN, Whyte MP, Reasner CA, Nippoldt TB, Tiegs RD, Hintz RL, Conover CA.
Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults.
J Clin Invest. 1998 May 15;101(10):2165-73.
PMID: 9593772

Reasner CA, Isley WL.
Endocrine emergencies. Recognizing clues to classic problems.
Postgrad Med. 1997 Mar;101(3):231-4, 237-8, 241-2. Review. Erratum in: Postgrad Med 1997 Nov;102(5):28.
PMID: 9074561

Whyte MP, Reasner CA 2nd.
Hepatitis C-associated osteosclerosis after blood transfusion.
Am J Med. 1997 Feb;102(2):219-20. No abstract available.
PMID: 9217575

Reasner CA, DeFronzo RA.
Diabetic nephropathy--can it be prevented?
Endocr Pract. 1996 May-Jun;2(3):205-8. No abstract available.
PMID: 15251542

Lee NA, Reasner CA.
Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM.
Diabetes Care. 1994 Dec;17(12):1449-52.
PMID: 7882815

Reasner CA 2nd, DeFronzo R.
Diabetic nephropathy: pathogenetic basis for treatment.
Contemp Intern Med. 1994 Oct;6(10):30-2, 35-40.
PMID: 10150289

Uy HL, Reasner CA 2nd.
Elevated thyroxine levels in a euthyroid patient. A search for the cause of euthyroid hyperthyroxinemia.
Postgrad Med. 1994 Oct;96(5):195-202. Review.
PMID: 7937417

Reasner CA, Stone MD, Hosking DJ, Ballah A, Mundy GR.
Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate.
J Clin Endocrinol Metab. 1993 Oct;77(4):1067-71.
PMID: 8408454

Nasir MA, Yee RW, Piest KL, Reasner CA 2nd.
Multiple endocrine neoplasia type III.
Cornea. 1991 Sep;10(5):454-9.
PMID: 1682109

Reasner CA, Mundy GR.
Diagnosis and treatment of osteoporosis.
Compr Ther. 1991 Aug;17(8):14-9. Review. No abstract available.
PMID: 1742973

Reasner CA 2nd, Isley WL.
Thyrotoxicosis in the critically ill.
Crit Care Clin. 1991 Jan;7(1):57-74. Review.
PMID: 2007220

Reasner CA 2nd, Dunn JF, Fetchick DA, Liel Y, Hollis BW, Epstein S, Shary J, Mundy GR, Bell NH.
Alteration of vitamin D metabolism in Mexican-Americans.
J Bone Miner Res. 1990 Jan;5(1):13-7.
PMID: 2309575